These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6988264)

  • 21. [Islet cell antibodies in diabetes mellitus (author's transl)].
    Pujol-Borrell R; Richart C
    Med Clin (Barc); 1980 Mar; 74(5):163-9. PubMed ID: 6991837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics.
    Kobayashi T; Sawano S; Itoh T; Sugimoto T; Tanaka T; Suwa S
    Endocrinol Jpn; 1981 Aug; 28(4):429-33. PubMed ID: 6763893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
    Berger B; Borg H; Fernlund P; Stenström G; Sundkvist G
    Diabet Med; 2006 Nov; 23(11):1180-5. PubMed ID: 17054592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.
    Mustonen A; Knip M; Huttunen NP; Puukka R; Käär ML; Akerblom HK
    Diabetologia; 1984 Oct; 27(4):421-6. PubMed ID: 6391985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA and pancreatic islet cell antibodies in diabetes.
    Morris PJ; Irvine WJ; Gray RS; Duncan LJ; Vaughan H; McCallum FJ; Campbell CJ; Farquhar JW
    Lancet; 1976 Sep; 2(7987):652-3. PubMed ID: 60516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
    Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
    Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual pancreatic function in insulin dependent diabetics.
    Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA
    Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European Association for the Study of Diabetes Annual Meeting, 1999: the beta-cell, autoimmunity, and insulin resistance.
    Bloomgarden ZT
    Diabetes Care; 2000 Aug; 23(8):1192-6. PubMed ID: 10937521
    [No Abstract]   [Full Text] [Related]  

  • 31. Islet-cell antibodies and HLA type in Japanese insulin-dependent diabetics.
    Sakurami T; Nagaoka K; Nabeya N; Imura H; Kuno S
    Endocrinol Jpn; 1980 Apr; 27(2):149-52. PubMed ID: 6997023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-islet cell antibodies in insulin-dependent diabetics. Preliminary study].
    Colimberti D; Mancino C; Notaro L; Pinzone F; Rinaldi A; Triolo G
    Minerva Med; 1978 Oct; 69(51):3515-8. PubMed ID: 366462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia.
    Peters WH; Lester FT; Kohnert KD; Hildmann W
    Exp Clin Endocrinol; 1986 Aug; 87(3):326-32. PubMed ID: 3536536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of WHO criteria for classification of newly diagnosed diabetics.
    Michaelis D; Rjasanowski I; Hildmann W; Kohnert KD; Richter KV
    Exp Clin Endocrinol; 1985 Feb; 85(1):61-9. PubMed ID: 3886412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children.
    Lernmark A; Hägglöf B; Freedman Z; Irvine J; Ludvigsson J; Holmgren G
    Diabetologia; 1981 Apr; 20(4):471-4. PubMed ID: 7016642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetics and their first-degree relatives.
    Barbosa J; Chavers B; Dunsworth T; Michael A
    Diabetes; 1982 Jul; 31(7):585-8. PubMed ID: 6761195
    [No Abstract]   [Full Text] [Related]  

  • 37. beta-cell function in children with diabetes.
    Ludvigsson J; Heding LG
    Diabetes; 1978; 27 Suppl 1():230-4. PubMed ID: 344114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determinación of islet-cell antibodies in different groups of diabetics (author's transl)].
    Pujol Borrell R; Richart C; Martí S; Martín C; Martínez-Vázquez JM; Bacardi Noguera R
    Med Clin (Barc); 1979 Jan; 72(1):13-6. PubMed ID: 372693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet-cell cytoplasmic antibodies in Japanese diabetics.
    Shinjyo T; Hirata Y; Maruyama H; Ishiba S; Matuura N; Fukushima N; Wakisaka A
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():265-9. PubMed ID: 6393434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Islet-cell antibodies in juvenile diabetes mellitus (author's transl)].
    Ludwig H; Schernthaner G; Mayr WR
    Dtsch Med Wochenschr; 1977 Aug; 102(34):1221-4. PubMed ID: 334498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.